Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey
Kathryn A. Mraz, Mev Dominguez–Valentin(Norwegian Cancer Society), Priyanka Kanth(University of Utah), Rachel Hodan(Cancer Institute (WIA)), José G. Guillem(University of North Carolina at Chapel Hill), Bryson W. Katona(University of Pennsylvania), Francesc Balaguer(Universitat de Barcelona), Linda Rodgers(Massachusetts General Hospital), Eduardo Vilar(The University of Texas MD Anderson Cancer Center), Charité Ricker(Keck Hospital of USC), Joshua Melson(Rush University Medical Center), Brian H. Shirts(University of Washington), David Liska(Cleveland Clinic), Sanjeevani Arora(Fox Chase Cancer Center), Dan Li(Kaiser Permanente Santa Clara Medical Center), Joanne Jeter(University of Utah), Kimberly Perez(Brigham and Women's Hospital)
Cited by 9
Related Papers
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
|JAMA Oncology|2016|721
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
|Cell|2021|586
Practice Parameters for the Management of Rectal Cancer (Revised)
|Diseases of the Colon & Rectum|2013|565
Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment
|Journal of Clinical Oncology|2009|390